Entero Therapeutics Inc
(NAS:ENTO)
$
1.03
0.0803 (8.46%)
Market Cap: 2.92 Mil
Enterprise Value: 67.99 Mil
PE Ratio: 0
PB Ratio: 0.13
GF Score: 33/100 Entero Therapeutics Inc (ENTO) Transcripts
- First Wave BioPharma Inc at SRAX Sequire Biotechnology Conference (Virtual) TranscriptFeb 02, 2023
- First Wave BioPharma Inc Extraordinary Shareholders Meeting TranscriptJan 13, 2023
- First Wave BioPharma Inc Annual Shareholders Meeting TranscriptAug 25, 2022
- First Wave BioPharma Inc Annual Shareholders Meeting TranscriptJan 14, 2022
- AzurRx BioPharma Inc at H C Wainwright Global Investment Conference (Virtual) TranscriptSep 13, 2021
- AzurRx BioPharma Inc Acquisition of First Wave Bio M&A Call TranscriptSep 13, 2021
- AzurRx BioPharma Inc at SRAX Sequire Rocky Mountain Microcap Conference (Virtual) TranscriptMay 26, 2021
- AzurRx BioPharma Inc at Investor Summit Group Virtual Summit TranscriptMay 17, 2021
- AzurRx BioPharma Inc Emerging Growth Conference TranscriptMay 12, 2021
- AzurRx BioPharma Inc to Report Topline Data from Phase 2b OPTION 2 Clinical Trial of MS1819 in Cystic Fibrosis - Conference Call TranscriptMar 31, 2021
- AzurRx BioPharma Inc at LD 500 Conference (Virtual) TranscriptSep 04, 2020
- 1